N. Susumu

D. Aoki, N. Susumu, K. Banno, 2011, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

A questionnaire survey of pharmacists regarding the clinical practice guidelines for the appropriate use of granulocyte-colony stimulating factors

K. Kiura, E. Baba, Y. Kato, 2018, Journal of Pharmaceutical Health Care and Sciences.

Hypertriglyceridemia is Frequent in Endometrial Cancer Survivors

D. Aoki, A. Hirasawa, N. Susumu, 2013, Japanese journal of clinical oncology.

How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey

H. Watari, D. Aoki, N. Susumu, 2015, International Journal of Clinical Oncology.

Clinicopathological study on para‐aortic lymph node metastasis without pelvic lymph node metastasis in endometrial cancer

D. Aoki, A. Hirasawa, N. Susumu, 2014, The journal of obstetrics and gynaecology research.

Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer

D. Aoki, N. Susumu, S. Nozawa, 2005, International Journal of Gynecologic Cancer.

Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study.

R. Mannel, N. Susumu, P. Rose, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sensitivity to cisplatin determined by the histoculture drug response assay and clinical response of endometrial cancer

D. Aoki, N. Susumu, Y. Udagawa, 2004, International Journal of Gynecologic Cancer.

P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix.

N. Susumu, M. Mukai, M. Ishikawa, 2003, Human pathology.

The Origin of Stroma Surrounding Epithelial Ovarian Cancer Cells

H. Tsuda, D. Aoki, E. Tominaga, 2013, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes.

D. Aoki, A. Hirasawa, N. Susumu, 2007, International journal of oncology.

Use of the Collagen Gel Droplet Embedded Drug Sensitivity Test to Determine Drug Sensitivity against Ovarian Mature Cystic Teratoma with Malignant Transformation to Adenocarcinoma: A Case Report

D. Aoki, N. Susumu, W. Yamagami, 2007, Chemotherapy.

Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen

I. Ishida, D. Aoki, N. Susumu, 2007, International Journal of Gynecologic Cancer.

Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation.

D. Aoki, E. Tominaga, N. Susumu, 1999, Gynecologic oncology.

HMMC-1

M. Fukuda, I. Ishida, D. Aoki, 2004, Clinical Cancer Research.

HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.

I. Ishida, D. Aoki, N. Susumu, 2004, Gynecologic oncology.

Lobular endocervical glandular hyperplasia and peritoneal pigmentation associated with Peutz-Jeghers syndrome due to a germline mutation of STK11.

D. Aoki, A. Hirasawa, N. Susumu, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression profiles of carcinosarcoma of the uterine corpus—are these similar to carcinoma or sarcoma?

H. Saya, M. Takano, H. Tsuda, 2012, Genes, chromosomes & cancer.

Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients

K. Kosaki, Y. Tanigawara, T. Zama, 2013, Journal of Human Genetics.

Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.

K. Kosaki, D. Aoki, A. Hirasawa, 2013, Japanese journal of clinical oncology.

Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma.

D. Aoki, N. Susumu, M. Takao, 2005, Gynecologic oncology.

Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study

H. Kuramoto, T. Jobo, D. Aoki, 2005, British Journal of Cancer.

Clinicopathologic Analysis With Immunohistochemistry for DNA Mismatch Repair Protein Expression in Synchronous Primary Endometrial and Ovarian Cancers

D. Aoki, E. Tominaga, A. Hirasawa, 2014, International Journal of Gynecologic Cancer.

A Comparison of Dye Versus Fluorescence Methods for Sentinel Lymph Node Mapping in Endometrial Cancer

D. Aoki, A. Hirasawa, N. Susumu, 2017, International Journal of Gynecologic Cancer.

Optimal cytoreductive surgery in patients with advanced uterine carcinosarcoma: A multi-institutional retrospective study from the Japanese gynecologic oncology group.

H. Watari, M. Yunokawa, D. Aoki, 2016, Gynecologic oncology.

Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group

H. Watari, M. Yunokawa, D. Aoki, 2016, International Journal of Clinical Oncology.

Role of Circulating Free Alu DNA in Endometrial Cancer

H. Tsuda, D. Aoki, N. Susumu, 2012, International Journal of Gynecologic Cancer.

Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical response

D. Aoki, N. Susumu, Y. Udagawa, 2004, International Journal of Gynecologic Cancer.

Complete remission of recurrent and refractory uterine epithelioid leiomyosarcoma using weekly administration of bevacizumab and temozolomide.

T. Goto, M. Takano, N. Susumu, 2011, European journal of obstetrics, gynecology, and reproductive biology.

Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary

T. Irimura, D. Aoki, N. Susumu, 2007, Cancer science.

Hereditary Endometrial Cancer: Lynch Syndrome

D. Aoki, N. Susumu, K. Masuda, 2013, Current Obstetrics and Gynecology Reports.

The importance of para-aortic lymph nodes in sentinel lymph node mapping for endometrial cancer by using hysteroscopic radio-isotope tracer injection combined with subserosal dye injection: Prospective study.

D. Aoki, N. Susumu, W. Yamagami, 2016, Gynecologic oncology.

Intermittent pneumatic compression for prevention of pulmonary thromboembolism after gynecologic surgery

D. Aoki, N. Susumu, H. Nomura, 2005, Thrombosis journal.

Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation

S. Hashimoto, D. Aoki, N. Susumu, 2017, The journal of obstetrics and gynaecology research.

Frequent Immune Responses to a Cancer/Testis Antigen, CAGE, in Patients with Microsatellite instability–Positive Endometrial Cancer

N. Susumu, S. Nozawa, Y. Kawakami, 2005, Clinical Cancer Research.

New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)

D. Aoki, E. Tominaga, N. Susumu, 2013, Oncology reports.

Clinical characteristics of prognostic factors in poorly differentiated (G3) endometrioid adenocarcinoma in Japan.

D. Aoki, N. Susumu, S. Nozawa, 2005, Japanese journal of clinical oncology.

Successful analysis of anticancer drug sensitivity by CD-DST using pleural fluid and ascites from patients with advanced ovarian cancer: case reports.

N. Susumu, S. Nozawa, K. Banno, 2005, Anticancer research.

Paclitaxel and SN‐38 Overcome Cisplatin Resistance of Ovarian Cancer Cell Lines by Down‐regulating the Influx and Efflux System of Cisplatin

T. Kubota, D. Aoki, N. Susumu, 2001, Japanese journal of cancer research : Gann.

Frequent Immune Responses to a Cancer / Testis Antigen , CAGE , in PatientswithMicrosatellite Instability ^ Positive

N. Susumu, S. Nozawa, Y. Kawakami, 2005 .

Endometrial Cancer as a Familial Tumor: Pathology and Molecular Carcinogenesis (Review)

D. Aoki, A. Hirasawa, N. Susumu, 2009, Current genomics.

Association of HNPCC and endometrial cancers

D. Aoki, A. Hirasawa, N. Susumu, 2004, International Journal of Clinical Oncology.

JGOG2033: Randomized phase III trial of whole pelvic radiotherapy vs cisplatin-based chemotherapy in patients with intermediate risk endometrial carcinoma

R. Kudo, N. Susumu, Y. Udagawa, 2005 .

UGT1A1 polymorphism as a prognostic indicator of stage I ovarian clear cell carcinoma patients treated with irinotecan

T. Mushiroda, D. Aoki, E. Tominaga, 2017, Japanese journal of clinical oncology.

Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review).

D. Aoki, N. Susumu, K. Masuda, 2012, International journal of oncology.

Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors.

D. Aoki, E. Tominaga, N. Susumu, 2013, Biomedical reports.

Osteoporosis is less frequent in endometrial cancer survivors with hypertriglyceridemia.

D. Aoki, E. Tominaga, A. Hirasawa, 2015, Japanese journal of clinical oncology.

The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma.

Y. Ohnishi, M. Hatae, H. Tsuda, 2010, European journal of obstetrics, gynecology, and reproductive biology.

Clinicopathologic manifestations of early‐onset endometrial cancer in Japanese women with a familial predisposition to cancer

D. Aoki, A. Hirasawa, N. Susumu, 2005, The journal of obstetrics and gynaecology research.

miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.

J. Inazawa, I. Imoto, D. Aoki, 2011, Cancer research.

Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer

D. Aoki, N. Susumu, K. Masuda, 2013, International journal of molecular sciences.

Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practice.

D. Aoki, N. Susumu, K. Masuda, 2012, Epigenomics.

Galactosyltransferase associated with tumor in patients with ovarian cancer: factors involved in elevation of serum galactosyltransferase.

D. Aoki, E. Saitoh, N. Susumu, 2003, International journal of oncology.

Subcellular Localization of Galactosyltransferase Associated with Tumors in Endometrial and Ovarian Cancer Cells

D. Aoki, N. Susumu, S. Nozawa, 2003 .

Subcellular localization of blood group Leb carbohydrate antigen (MSN-1-reactive antigen) in endometrial cancer cells.

D. Aoki, N. Susumu, S. Nozawa, 1993, Cancer research.

Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546

D. Aoki, N. Susumu, Y. Udagawa, 2004, International Journal of Gynecologic Cancer.

Identification of a novel uterine leiomyoma GWAS locus in a Japanese population

Shoichiro Tsugane, Takako Takai-Igarashi, Yoichiro Kamatani, 2020, Scientific Reports.

Imbalanced expression of TAN-1 and human Notch4 in endometrial cancers.

D. Aoki, N. Susumu, Y. Udagawa, 2000, International journal of oncology.

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary

A. Oza, A. Okamoto, J. Ledermann, 2014, International Journal of Gynecologic Cancer.

Unfavorable prognostic factors associated with high frequency of microsatellite instability and comparative genomic hybridization analysis in endometrial cancer.

J. Inazawa, I. Imoto, D. Aoki, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

P16ink4a overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix

N. Susumu, M. Mukai, M. Ishikawa, 2003 .

Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer

Y. Kanai, Eri Arai, Yoriko Takahashi, 2019, Carcinogenesis.

Family history and BRCA1/BRCA2 status among Japanese ovarian cancer patients and occult cancer in a BRCA1 mutant case.

K. Kosaki, D. Aoki, E. Tominaga, 2014, Japanese journal of clinical oncology.

Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets.

J. Inazawa, I. Imoto, D. Aoki, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Intratumoral CD8+ Lymphocyte Infiltration as a Prognostic Factor and Its Relationship With Cyclooxygenase 2 Expression and Microsatellite Instability in Endometrial Cancer

D. Aoki, A. Hirasawa, N. Susumu, 2015, International Journal of Gynecologic Cancer.

Lobular endocervical glandular hyperplasia and peritoneal pigmentation associated with Peutz-Jeghers syndrome due to a germline mutation of STK11.

D. Aoki, A. Hirasawa, N. Susumu, 2012 .

Current status of molecular-targeted drugs for endometrial cancer (Review)

D. Aoki, E. Tominaga, N. Susumu, 2013, Molecular and clinical oncology.

Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells

D. Aoki, E. Tominaga, N. Susumu, 2012, Oncology reports.

Preoperative Differential Diagnosis of Minimal Deviation Adenocarcinoma and Lobular Endocervical Glandular Hyperplasia of the Uterine Cervix: A Multicenter Study of Clinicopathology and Magnetic Resonance Imaging Findings

K. Togashi, H. Tsuda, T. Kaku, 2011, International Journal of Gynecologic Cancer.

A tumor of the uterine cervix with a complex histology in a Peutz-Jeghers syndrome patient with genomic deletion of the STK11 exon 1 region.

D. Aoki, A. Hirasawa, N. Susumu, 2014, Future oncology.

Biomarkers in endometrial cancer: Possible clinical applications (Review).

D. Aoki, E. Tominaga, N. Susumu, 2012, Oncology letters.

Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer

H. Tsuda, K. Masuda, I. Imoto, 2017, Oncotarget.

Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study

E. Stanbridge, N. Susumu, K. Darcy, 2010, British Journal of Cancer.

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine Serous Carcinoma

D. Provencher, R. Glasspool, G. Kristensen, 2014, International Journal of Gynecologic Cancer.

MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review).

Yusuke Kobayashi, Kouji Banno, Nobuyuki Susumu, 2010, Oncology letters.

Association of 17 q 21-q 24 Gain in Ovarian Clear Cell Adenocarcinomas with Poor Prognosis and Identification of PPM 1 D and APPBP 2 as Likely Amplification Targets 1

J. Inazawa, I. Imoto, D. Aoki, 2003 .

Simultaneous analysis of the gene expression profiles of cancer and stromal cells in endometrial cancer

S. Hashimoto, M. Takano, H. Tsuda, 2014, Genes, chromosomes & cancer.

Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics

D. Aoki, N. Susumu, K. Masuda, 2012, Biochemistry research international.

Sentinel Node Navigation Surgery for Endometrial Cancer

D. Aoki, A. Hirasawa, N. Susumu, 2019, Comprehensive Gynecology and Obstetrics.

Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study

T. Baba, M. Shimada, H. Katabuchi, 2021, International Journal of Clinical Oncology.

Abdominal radical trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer in a series of 61 women.

D. Aoki, N. Susumu, K. Kameyama, 2009, Gynecologic oncology.

Anisakiasis mimics cancer recurrence: two cases of extragastrointestinal anisakiasis suspected to be recurrence of gynecological cancer on PET-CT and molecular biological investigation

Atsushi Suzuki, Hiromu Sugiyama, Daisuke Aoki, 2016, BMC Medical Imaging.

Abdominal radical trachelectomy as a fertility-sparing procedure in women with early stage cervical cancer in a series of 61 women

D. Aoki, N. Susumu, K. Kameyama, 2010 .

Epimutation in DNA Mismatch Repair (MMR) Genes

D. Aoki, N. Susumu, K. Masuda, 2013 .

Epimutation and cancer: A new carcinogenic mechanism of Lynch syndrome

D. Aoki, E. Tominaga, N. Susumu, 2012, International journal of oncology.

Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?

D. Aoki, A. Hirasawa, N. Susumu, 2018, Journal of gynecologic oncology.

Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles

Y. Kanai, Mao Fujimoto, Eri Arai, 2022, Journal of gynecologic oncology.

Identification of germline MSH2 gene mutations in endometrial cancer not fulfilling the new clinical criteria for hereditary nonpolyposis colorectal cancer.

D. Aoki, A. Hirasawa, N. Susumu, 2003, Cancer genetics and cytogenetics.

Clinical implications of next‐generation sequencing‐based panel tests for malignant ovarian tumors

D. Aoki, N. Susumu, W. Yamagami, 2020, Cancer medicine.

Aberrant DNA Methylation in Endometrial Cancer

D. Aoki, A. Hirasawa, N. Susumu, 2012 .

Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients.

D. Aoki, N. Susumu, K. Banno, 2006, Anticancer research.

Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers

H. Tsuda, D. Aoki, N. Susumu, 2004, International Journal of Gynecologic Cancer.

J. Inazawa, H. Tsuda, D. Aoki, 2004, International Journal of Gynecologic Cancer.

Epigenetic Aberrant Hypermethylation of DNA in Endometrial Cancer: Application as a Biomarker

D. Aoki, N. Susumu, K. Masuda, 2011 .

A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: potential new therapy for ovarian clear cell adenocarcinoma.

D. Aoki, N. Susumu, F. Hosoi, 2008, Gynecologic oncology.

A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma.

D. Aoki, N. Susumu, S. Nozawa, 2004, Gynecologic oncology.

Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification.

T. Irimura, D. Aoki, N. Susumu, 2006, Oncology research.

Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancer.

Y. Ohashi, K. Hasegawa, K. Ushijima, 2009, Anticancer research.

What Is the Role of Cytotoxic Chemotherapy in Advanced Cervical Cancer

N. Susumu, A. Pant, S. Sagae, 2014 .

Analysis of candidate target genes for mononucleotide repeat mutation in microsatellite instability-high (MSI-H) endometrial cancer.

D. Aoki, A. Hirasawa, N. Susumu, 2009, International journal of oncology.

Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review).

D. Aoki, A. Hirasawa, N. Susumu, 2009, Oncology reports.

Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.

D. Aoki, A. Hirasawa, N. Susumu, 2006, Oncology reports.

Establishment and characterization of the RMG-V cell line from human ovarian clear cell adenocarcinoma

D. Aoki, N. Susumu, S. Nozawa, 2008, Human Cell.

MicroRNAs in endometrial cancer

D. Aoki, N. Susumu, W. Yamagami, 2013, International Journal of Clinical Oncology.

Metformin: A possible drug for treatment of endometrial cancer

D. Aoki, N. Susumu, K. Masuda, 2012 .

Loss of integrin α3 expression is associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells

D. Aoki, N. Susumu, S. Oie, 2008, Human Cell.

Lymph Node Metastasis in Grossly Apparent Stages I and II Epithelial Ovarian Cancer

H. Tsuda, D. Aoki, E. Tominaga, 2009, International Journal of Gynecologic Cancer.

Carcinoma of the Lower Uterine Segment (LUS): Clinicopathological Characteristics and Association with Lynch Syndrome

D. Aoki, A. Hirasawa, N. Susumu, 2011, Current genomics.

Relationship of lower uterine segment cancer with Lynch syndrome: A novel case with an hMLH1 germline mutation

D. Aoki, E. Tominaga, A. Hirasawa, 2012, Oncology reports.

Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization.

S. Hirohashi, J. Inazawa, H. Tsuda, 1997, The American journal of pathology.

Relationship of aberrant DNA hypermethylation of CHFR with sensitivity to taxanes in endometrial cancer.

D. Aoki, A. Hirasawa, N. Susumu, 2007, Oncology reports.

Distinguishing between lymphangioleiomyomatosis and carcinomatous peritonitis in a patient with ovarian cancer.

T. Betsuyaku, D. Aoki, A. Hirasawa, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Two Japanese kindreds occurring endometrial cancer meeting new clinical criteria for hereditary non‐polyposis colorectal cancer (HNPCC), Amsterdam Criteria II

D. Aoki, A. Hirasawa, N. Susumu, 2004, The journal of obstetrics and gynaecology research.

Analysis of a correlation between the BRAF V600E mutation and abnormal DNA mismatch repair in patients with sporadic endometrial cancer.

M. Kobayashi, D. Aoki, A. Hirasawa, 2009, International journal of oncology.

Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia

T. Hamatani, D. Aoki, A. Hirasawa, 2016, Reproductive Biology and Endocrinology.

Germline multigene panel testing revealed a BRCA2 pathogenic variant in a patient with suspected Lynch syndrome

Teruhiko Yoshida, K. Kosaki, D. Aoki, 2020, International Cancer Conference Journal.

Effects of third-line chemotherapy for women with recurrent ovarian cancer who received platinum/taxane regimens as first-line chemotherapy.

D. Aoki, E. Tominaga, N. Susumu, 2010, European Journal of Gynaecological Oncology.

Identification of a novel uterine leiomyoma GWAS locus in a Japanese population

Y. Kamatani, C. Tanikawa, K. Matsuda, 2020, Scientific Reports.

Can ABCF2 protein expression predict the prognosis of uterine cancer?

Y. Miyagi, D. Aoki, A. Hirasawa, 2008, British Journal of Cancer.

A case of pulmonary type of ovarian small cell carcinoma

D. Aoki, N. Susumu, M. Mukai, 2007, The journal of obstetrics and gynaecology research.

Effectiveness of third-line chemotherapy in recurrent ovarian cancer patients.

S. Hashimoto, D. Aoki, E. Tominaga, 2015, European Journal of Gynaecological Oncology.

Preoperative and intraoperative assessment of myometrial invasion in endometrial cancer: comparison of magnetic resonance imaging and frozen sections

Li-yu Lin, D. Aoki, N. Susumu, 2013, Acta obstetricia et gynecologica Scandinavica.

Relationship between DNA Mismatch Repair Deficiency and Endometrial Cancer

D. Aoki, A. Hirasawa, N. Susumu, 2011, Molecular biology international.

DNA Mismatch Repair (MMR) Genes and Endometrial Cancer

D. Aoki, A. Hirasawa, N. Susumu, 2011 .

Retrospective Analysis on the Feasibility and Efficacy of Docetaxel-Cisplatin Therapy for Recurrent Endometrial Cancer.

D. Aoki, A. Hirasawa, N. Susumu, 2016, Anticancer research.

Intravenous low-grade endometrial stromal sarcoma with intracardiac extension: A CASE OF inaccurate tumor location on contrast-enhanced computed tomography.

D. Aoki, N. Susumu, W. Yamagami, 2016, Molecular and clinical oncology.

Intermittent pneumatic compression for prevention of pulmonary thromboembolism after gynecologic surgery

D. Aoki, N. Susumu, H. Nomura, 2005, Thrombosis journal.

Family history and BRCA1/BRCA2 status among Japanese ovarian cancer patients and occult cancer in a BRCA1 mutant case.

K. Kosaki, D. Aoki, E. Tominaga, 2014, Japanese Journal of Clinical Oncology.

Specific expression of hepatocyte nuclear factor‐1β in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis

M. Sakamoto, D. Aoki, N. Susumu, 2007, Cancer science.

Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma.

H. Tsuda, N. Susumu, K. Takehara, 2020, Gynecologic oncology.

A phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: A Gynecologic Oncology Group (GOG) study.

R. Mannel, N. Susumu, P. Rose, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Loss of integrin alpha3 expression associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells.

D. Aoki, N. Susumu, N. Suzuki, 2005, Human cell.

Glycoconjugates in Histochemistry and Cytochemistry

K. Umesono, T. Higuchi, H. Yokota, 1998 .